Global Age-Related Macular Degeneration Market and Competitive Landscape – 2017

Best Price Guarantee	Publisher	Published Date	SKU
from $3,990	Fore Pharma	August, 2017	FPCI15450549

Best Price Guarantee
Price	from $3,990
Publisher	Fore Pharma
Published Date	August, 2017
SKU	FPCI15450549

Global Age-Related Macular Degeneration Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Global Age-Related Macular Degeneration Market and Competitive Landscape – 2017, provides comprehensive insights into Age-Related Macular Degeneration pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Age-Related Macular Degeneration market size and drug sales. This research also provides insights into Age-Related Macular Degeneration epidemiology and late stage pipeline.
The report is classified into twelve sections – Age-Related Macular Degeneration overview with definitions, symptoms, etiology, diagnosis, treatment options; Age-Related Macular Degeneration pipeline insights covering late stage clinical trials pipeline; Age-Related Macular Degeneration prevalence trends by countries; Age-Related Macular Degeneration market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries – US, Germany, France, Italy, Spain, UK, Japan, Europe, Global.

Research Scope:

Age-Related Macular Degeneration pipeline: Find out the drugs in clinical trials for Age-Related Macular Degeneration by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
Age-Related Macular Degeneration epidemiology: Find out the prevalence of Age-Related Macular Degeneration by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
Age-Related Macular Degeneration products: Identify key products marketed and prescribed for Age-Related Macular Degeneration by brand name, by molecule, by company, by branded / generic, by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
Age-Related Macular Degeneration market size: Find out the market size for Age-Related Macular Degeneration drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
Age-Related Macular Degeneration drug sales: Find out the sales of Age-Related Macular Degeneration drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
Age-Related Macular Degeneration drugs sales forecast: Sales forecast for Age-Related Macular Degeneration drugs to 2021 by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
Age-Related Macular Degeneration market share analysis: Find out the market shares of Age-Related Macular Degeneration drugs and outlook by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan

Benefits of this Research: The research helps executives to

Evaluate commercial market opportunities for Age-Related Macular Degeneration drugs
Synthesize insights for business development & licensing
Track market size, competitor drug sales, market shares in Age-Related Macular Degeneration market
Develop in-depth knowledge of competition and markets
Analyze sales data to update your brand planning trackers
Develop tactics and strategies to take advantage of opportunities in the market
Track market trends and analyze key events in Age-Related Macular Degeneration market
Develop forecast models, healthcare frameworks, or economic models
Answer key business questions; supports decision making in R&D to long term marketing strategies

1. Age-Related Macular Degeneration: Disease Overview: 1.1. Age-Related Macular Degeneration Symptoms; 1.2. Age-Related Macular Degeneration Etiology; 1.3. Age-Related Macular Degeneration Diagnosis; 1.4. Age-Related Macular Degeneration Treatment Options
2. Age-Related Macular Degeneration Pipeline Insights: 2.1. Age-Related Macular Degeneration Phase 3 Clinical Trials; 2.2. Age-Related Macular Degeneration Phase 2 Clinical Trials; 2.3. Age-Related Macular Degeneration Phase 1 Clinical Trials
3. Age-Related Macular Degeneration Epidemiology Analysis
4. US Age-Related Macular Degeneration Market Insights: 4.1. Marketed Products for Age-Related Macular Degeneration in US; 4.2. US Age-Related Macular Degeneration Market Size & Forecast; 4.3. US Age-Related Macular Degeneration Product Sales Forecast; 4.4. US Age-Related Macular Degeneration Market Share Analysis
5. Germany Age-Related Macular Degeneration Market Insights: 5.1. Marketed Products for Age-Related Macular Degeneration in Germany; 5.2. Germany Age-Related Macular Degeneration Market Size & Forecast; 5.3. Germany Age-Related Macular Degeneration Product Sales Forecast; 5.4. Germany Age-Related Macular Degeneration Market Share Analysis
6. France Age-Related Macular Degeneration Market Insights: 6.1. Marketed Products for Age-Related Macular Degeneration in France; 6.2. France Age-Related Macular Degeneration Market Size & Forecast; 6.3. France Age-Related Macular Degeneration Product Sales Forecast; 6.4. France Age-Related Macular Degeneration Market Share Analysis
7. Italy Age-Related Macular Degeneration Market Insights: 7.1. Marketed Products for Age-Related Macular Degeneration in Italy; 7.2. Italy Age-Related Macular Degeneration Market Size & Forecast; 7.3. Italy Age-Related Macular Degeneration Product Sales Forecast; 7.4. Italy Age-Related Macular Degeneration Market Share Analysis
8. Spain Age-Related Macular Degeneration Market Insights: 8.1. Marketed Products for Age-Related Macular Degeneration in Spain; 8.2. Spain Age-Related Macular Degeneration Market Size & Forecast; 8.3. Spain Age-Related Macular Degeneration Product Sales Forecast; 8.4. Spain Age-Related Macular Degeneration Market Share Analysis
9. UK Age-Related Macular Degeneration Market Insights: 9.1. Marketed Products for Age-Related Macular Degeneration in UK; 9.2. UK Age-Related Macular Degeneration Market Size & Forecast; 9.3. UK Age-Related Macular Degeneration Product Sales Forecast; 9.4. UK Age-Related Macular Degeneration Market Share Analysis
10. Europe Age-Related Macular Degeneration Market Insights: 10.1. Europe Age-Related Macular Degeneration Market Size & Forecast; 10.2. Europe Age-Related Macular Degeneration Product Sales Forecast; 10.3. Europe Age-Related Macular Degeneration Market Share Analysis
11. Japan Age-Related Macular Degeneration Market Insights: 11.1. Marketed Products for Age-Related Macular Degeneration in Japan; 11.2. Japan Age-Related Macular Degeneration Market Size & Forecast; 11.3. Japan Age-Related Macular Degeneration Product Sales Forecast; 11.4. Japan Age-Related Macular Degeneration Market Share Analysis
12. Global Age-Related Macular Degeneration Market Insights: 12.1. Global Age-Related Macular Degeneration Market Size & Forecast; 12.2. Global Age-Related Macular Degeneration Product Sales Forecast; 12.3. Global Age-Related Macular Degeneration Market Share Analysis
13. Research Methodology
LIST OF TABLES: Table 1: Age-Related Macular Degeneration Phase 3 Clinical Trials, Global, 2017; Table 2: Age-Related Macular Degeneration Phase 2 Clinical Trials, Global, 2017; Table 3: Age-Related Macular Degeneration Phase 1 Clinical Trials, Global, 2017; Table 4: Age-Related Macular Degeneration Prevalence by G7 Countries, 2012 - 2021; Table 5: Marketed Products for Age-Related Macular Degeneration in US, 2017; Table 6: US Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021; Table 7: US Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021; Table 8: US Age-Related Macular Degeneration Market Trends, 2012 - 2021; Table 9: Marketed Products for Age-Related Macular Degeneration in Germany, 2017; Table 10: Germany Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021; Table 11: Germany Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021; Table 12: Germany Age-Related Macular Degeneration Market Trends, 2012 - 2021; Table 13: Marketed Products for Age-Related Macular Degeneration in France, 2017; Table 14: France Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021; Table 15: France Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021; Table 16: France Age-Related Macular Degeneration Market Trends, 2012 - 2021; Table 17: Marketed Products for Age-Related Macular Degeneration in Italy, 2017; Table 18: Italy Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021; Table 19: Italy Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021; Table 20: Italy Age-Related Macular Degeneration Market Trends, 2012 - 2021; Table 21: Marketed Products for Age-Related Macular Degeneration in Spain, 2017; Table 22: Spain Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021; Table 23: Spain Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021; Table 24: Spain Age-Related Macular Degeneration Market Trends, 2012 - 2021; Table 25: Marketed Products for Age-Related Macular Degeneration in UK, 2017; Table 26: UK Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021; Table 27: UK Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021; Table 28: UK Age-Related Macular Degeneration Market Trends, 2012 - 2021; Table 29: Europe Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021; Table 30: Europe Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021; Table 31: Marketed Products for Age-Related Macular Degeneration in Japan, 2017; Table 32: Japan Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021; Table 33: Japan Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021; Table 34: Japan Age-Related Macular Degeneration Market Trends, 2012 - 2021; Table 35: Global Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021; Table 36: Global Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
LIST OF FIGURES: Figure 1: Age-Related Macular Degeneration Pipeline by Phase (%), Global, 2017; Figure 2: Age-Related Macular Degeneration Prevalence by G7 Countries, 2012 - 2021; Figure 3: US Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021; Figure 4: US Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021; Figure 5: US Age-Related Macular Degeneration Market Share by Products (%), 2016; Figure 6: US Age-Related Macular Degeneration Market - Future Market Share (%), 2021; Figure 7: Germany Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021; Figure 8: Germany Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021; Figure 9: Germany Age-Related Macular Degeneration Market Share by Products (%), 2016; Figure 10: Germany Age-Related Macular Degeneration Market - Future Market Share (%), 2021; Figure 11: France Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021; Figure 12: France Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021; Figure 13: France Age-Related Macular Degeneration Market Share by Products (%), 2016; Figure 14: France Age-Related Macular Degeneration Market - Future Market Share (%), 2021; Figure 15: Italy Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021; Figure 16: Italy Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021; Figure 17: Italy Age-Related Macular Degeneration Market Share by Products (%), 2016; Figure 18: Italy Age-Related Macular Degeneration Market - Future Market Share (%), 2021; Figure 19: Spain Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021; Figure 20: Spain Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021; Figure 21: Spain Age-Related Macular Degeneration Market Share by Products (%), 2016; Figure 22: Spain Age-Related Macular Degeneration Market - Future Market Share (%), 2021; Figure 23: UK Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021; Figure 24: UK Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021; Figure 25: UK Age-Related Macular Degeneration Market Share by Products (%), 2016; Figure 26: UK Age-Related Macular Degeneration Market - Future Market Share (%), 2021; Figure 27: Europe Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021; Figure 28: Europe Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021; Figure 29: Europe Age-Related Macular Degeneration Market Share by Products (%), 2016; Figure 30: Europe Age-Related Macular Degeneration Market - Future Market Share (%), 2021; Figure 31: Japan Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021; Figure 32: Japan Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021; Figure 33: Japan Age-Related Macular Degeneration Market Share by Products (%), 2016; Figure 34: Japan Age-Related Macular Degeneration Market - Future Market Share (%), 2021; Figure 35: Global Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021; Figure 36: Global Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021; Figure 37: Global Age-Related Macular Degeneration Market Share by Products (%), 2016; Figure 38: Global Age-Related Macular Degeneration Market - Future Market Share (%), 2021